New company, Velsera, represents Summa Equity's vision to improve global health outcomes
Boston, San Francisco, Stockholm, 12 January 2023 - New company Velsera was announced today at the...
Press Releases
Read about Pierian and our partners in the news.
Filter by Date
Pierian Selected by PreCheck Health Services to Support Hereditary Cancer Testing for Providers and Patients
Pierian®, a global leader in advanced clinical genomics technology and services, announced a...
Pierian and P4 Diagnostix Collaborate to Help Physician-Owned Laboratories
Pierian®, a global leader in advanced clinical genomics technology and services, is pleased to...
Pierian and Genome Medical Announce Collaboration to Optimize Genomic Testing Programs
We are excited to announce our new partnership with Genome Medical, the leading telehealth provider...
Pierian and Syapse Collaborate with Health Systems, Leveraging Data to Power Precision Oncology
ST. LOUIS, June 15, 2022 --Pierian®, a global leader in advanced clinical genomics technology and...
Pierian and Biodesix Partner to Advance Lung Cancer Diagnostics
Partnership enables comprehensive clinical information to deliver optimal patient care
Pierian Closes up to $47.5 Million of Growth Capital
Funds to drive commercial expansion as growing number of facilities bring genomics into communities...
Pierian Partners with Florida Cancer Specialists & Research Institute to Advance Cancer Care
Partnership enables local oncology genomic testing to broaden patient access to expedited,...
Pierian and Intermountain Healthcare Combine Expertise to Advance Myriad Genetics’ Tumor Test Offering
Comprehensive Genetic Profiling Supplements Germline and Companion Diagnostic Results to Provide...
Pierian Announces the Appointment of Lindsay Mateo as Chief Business Officer
ST. LOUIS, MO., March 2, 2021 — Pierian, the global leader in clinical genomics knowledge, today...
Pierian partners with the Belgian Society of Medical Oncology (BSMO) to evaluate potential of comprehensive genomic profiling in late-stage cancer real-world setting across Belgium
BALLETT Study will measure the impact of comprehensive genomic profiling on access to, and uptake...
Pierian Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets
Additional Illumina assays to be combined with the Pierian platform to reduce time, cost, and...
Pierian and Pillar Biosciences Announce Partnership to Support Precision Cancer Care
Multiple targeted assays from Pillar Biosciences to be combined with the Pierian platform to reduce...
Pierian and University Hospital of Augsburg Announce Strategic Partnership
Collaboration will create integrated clinical interpretation and reporting solution
Intermountain Healthcare Selects Pierian Clinical Genomics Solution
Intermountain Healthcare joins Pierian’s partner network to accelerate precision medicine
Pierian Closes Series B Financing Round
Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst...
Pierian Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics
Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform...
2bPrecise and Pierian Collaborate to Deliver a Comprehensive Precision Medicine Solution
As posted on BusinessWire
PierianDx Announces TriCore Reference Laboratories as the Newest Customer to its Partner Sharing Network
PierianDx, the leading clinical genomics technology company that enables precision medicine,...
PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution
PierianDx, the leading genomics technology company that enables precision medicine programs and...
Cleveland Clinic Joins Pierian’s Customer Network to Accelerate Precision Medicine
Pierian announced today that Cleveland Clinic will utilize its integrated “one space” workflow and...
PierianDx Accelerates Precision Medicine with Fully Integrated Workflow and Interpretation Solution Supporting Illumina TruSight Tumor 170
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced...
PierianDx Announces Clinical Microarray Technology Will Be Integrated into its End-to- End Genomics Platform for Clinical Labs
ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting,...
PierianDx Acquires Tute Genomics
Company Extends Ability to Deliver a Unified Sample-to-Report Software Platform for Clinical Labs...
PierianDx and ArcherDX Announce Partnership Benefiting NGS Clinical Labs
ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements...
PierianDx Announces 10 New Customers in Q1 2016, Expands Partner Sharing Network to 24 Members
ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic analysis, interpretation and...
PierianDx and Syapse Partner to Accelerate Precision Medicine Programs for Healthcare Providers
ST. LOUIS, MO and PALO ALTO, CA – PierianDx, makers of the leading bioinformatics platform for...
Aeon Clinical Laboratories Leverages Pierian Bioinformatics Platform to Enhance Genomic Test Offering
ST LOUIS, MO/GAINSVILLE, GA – Pierian, the forerunner in clinical genomic informatics, and Aeon...
MDL Partners with PierianDx to Rapidly Launch Next Generation Sequencing Tests for Breast Cancer
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that...
UVA to use PierianDx Platform to Analyze, Report on Cancer Patients’ Genome Data
ST LOUIS, MO and CHARLOTTESVILLE, VA – PierianDx announced today that the University of Virginia...
Inova Joins PierianDx Partner Network to Provide Precision Medicine to Cancer Patients
ST LOUIS, MO and FALLS CHURCH, VA – PierianDx announced today that the Inova Translational Medicine...
Moffitt Cancer Center and the University of Vermont Join PierianDx Partner Network
ST. LOUIS MO – PierianDx announced today that Moffitt Cancer Center in Tampa, FL and Fletcher Allen...
